We will upload information about the latest recipients to have been awarded HRC funding for all of our funding opportunities as this information becomes officially available.

The information provided is for ‘year to date’ funding.

Previous Recipient List

  • 2014 Funding Round – Project
    Dr Peter Bergin
    Auckland District Health Board
    Incidence study of Status Epilepticus in the greater Auckland region
    $671,783
    60 months
  • 2016 Funding Round - Programme
    Professor Michael Berridge
    Malaghan Institute of Medical Research
    Intercellular mitochondrial transfer in glioblastoma
    $1,095,885
    36 months
  • 2008 Funding Round
    Associate Professor David Bilkey
    University of Otago, Dunedin
    Hippocampal processing of context in schizophrenia
    $796,117
    36 months
  • 2006 Funding Round
    Dr David Bilkey
    University of Otago
    Hippocampal processing of context in schizophrenia
    $415,008
    24 months
  • 2009 Funding Round
    Associate Professor Peter Black
    The University of Auckland
    The effect of an inhaler with ringtones on asthma control and school attendance
    $428,355
    24 months
  • 2006 Funding Round
    Associate Professor Tony Blakely
    University of Otago
    Cancer trends: Ethnic and socio-economic trends in cancer incidence and survival
    $924,356
    36 months
  • 2007 Funding Round
    Dr Francis Bloomfield
    The University of Auckland
    Periconceptional regulation of fetal growth and adult physiology: studies in twins
    $682,734
    24 months
  • 2014 Funding Round – Project
    Professor Frank Bloomfield
    The University of Auckland
    ProViDe RCT: Does better early nutrition in preterm babies improve development?
    $1,194,159
    60 months
  • Project
    Professor Frank Bloomfield
    University of Auckland
    Reducing inequity through timely detection of critical congenital heart disease
    $1,184,577
    36 months
  • 2012 Funding Round
    Dr Mark Bolland
    The University of Auckland
    Zoledronic Acid and Fracture Prevention in Early Postmenopausal Women
    $1,159,604
    60 months
  • 2016 Funding Round - Project
    Associate Professor Mark Bolland
    University of Auckland
    Zoledronic acid and fracture prevention in early postmenopausal women
    $962,994
    48 months
  • 2007 Funding Round
    Ms Belinda Borell
    Massey University
    Conferred privilege and structural advantage - the health implications
    $852,482
    36 months
  • 2011 Funding Round
    Dr Amohia Boulton
    Te Maruo Ruahine Trust/Whakauae Research for Maori Health & Development
    Supporting Traditional Rongoa Practice in Contemporary Health Care Settings
    $1,023,301
    36 months
  • Project
    Dr Amohia Boulton
    Whakauae Research Services Limited
    D3: Data, decision-making and development: Using data to improve health outcomes
    $1,199,996
    36 months
  • 2010 Funding Round
    Professor Antony Braithwaite
    University of Otago
    Can isoforms of the p53 tumour suppressor cause cancer?
    $1,158,492
    36 months
  • 2013 Funding Round
    Professor Antony Braithwaite
    University of Otago, Dunedin
    Does the D133p53 isoform promote cancer invasion and metastasis?
    $1,185,648
    36 months
  • 2014 Funding Round – Project
    Professor Anthony Braithwaite
    University of Otago, Dunedin
    A role for p53 isoforms in inflammatory disease
    $1,176,905
    36 months
  • 2015 Funding Round - Project
    Professor Bernhard Breier
    Massey University, Auckland
    The gut microbiome: a new pathway to obesity prevention and metabolic health
    $1,199,468
    36 months
  • 2016 Funding Round - Project
    Professor Margaret Brimble
    University of Auckland
    New generation lipopeptide antimicrobial agents using patented CLipPA technology
    $1,199,021
    36 months
  • Projects
    Professor Margaret Brimble
    The University of Auckland
    Naturally occurring peptaibols: “Magic bullets” for targeting breast cancer
    $1,195,373
    36 months